Molecular mimicry: CLIP, MHC Class II supermotifs and MAIDS

Transgenic mouse model of IgM+ lymphoproliferative disease mimicking Waldenström macroglobulinemia.

Blood cancer journal·2016

(18)F-FDG-PET/CT imaging in an IL-6- and MYC-driven mouse model of human multiple myeloma affords objective evaluation of plasma cell tumor progression and therapeutic response to the proteasome inhibitor ixazomib.

Blood cancer journal·2013

Prdm14 initiates lymphoblastic leukemia after expanding a population of cells resembling common lymphoid progenitors.

Oncogene·2011

The histopathologic and molecular basis for the diagnosis of histiocytic sarcoma and histiocyte-associated lymphoma of mice.

Veterinary pathology·2010

Ectopic expression of wild-type FGFR3 cooperates with MYC to accelerate development of B-cell lineage neoplasms.

Leukemia·2010

Citrobacter-induced colitis in mice with murine acquired immunodeficiency syndrome.

Veterinary pathology·2010

The origin and significance of anti-DNA antibodies.

Immunology today·2014

Mutations of class II MHC molecules.

Immunology today·2014

Antigen processing at the molecular level.

Immunology today·2014

Phenotypically and functionally distinct T-cell subsets in anti-tumor responses.

Immunology today·2014

Are MHC class II-restricted cytotoxic T lymphocytes important?

Immunology today·2014

Complement and the regulation of humoral immune responses.

Immunology today·2014

Rational drug design, synthetic and artificial intelligence approaches for bioactive heterocycles: advances and perspectives.

Future medicinal chemistry·2026

Design and synthesis of 1,3,4-oxadiazole-tethered N-substituted isatin hybrids as SARS-CoV-2 main protease inhibitors: biological evaluation, kinetic investigation, and in silico studies.

RSC advances·2026

Teaching diffusion models physics: reinforcement learning for physically valid diffusion-based docking.

Chemical science·2026

Similarity-Enhanced Representation Learning of Non-Canonical Amino Acids for Therapeutic Peptide Modeling.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Machine Learning Approaches for Interpretable Antibody Property Prediction Using Structural Data.

Methods in molecular biology (Clifton, N.J.)·2026

New thinking for the next generation of antimalarials.

EMBO molecular medicine·2026

Related Experiment Videos

Molecular mimicry: CLIP, MHC Class II supermotifs and MAIDS

Related Concept Videos

Transgenic mouse model of IgM+ lymphoproliferative disease mimicking Waldenström macroglobulinemia.

(18)F-FDG-PET/CT imaging in an IL-6- and MYC-driven mouse model of human multiple myeloma affords objective evaluation of plasma cell tumor progression and therapeutic response to the proteasome inhibitor ixazomib.

Prdm14 initiates lymphoblastic leukemia after expanding a population of cells resembling common lymphoid progenitors.

The histopathologic and molecular basis for the diagnosis of histiocytic sarcoma and histiocyte-associated lymphoma of mice.

Ectopic expression of wild-type FGFR3 cooperates with MYC to accelerate development of B-cell lineage neoplasms.

Citrobacter-induced colitis in mice with murine acquired immunodeficiency syndrome.

The origin and significance of anti-DNA antibodies.

Mutations of class II MHC molecules.

Antigen processing at the molecular level.

Phenotypically and functionally distinct T-cell subsets in anti-tumor responses.

Are MHC class II-restricted cytotoxic T lymphocytes important?

Complement and the regulation of humoral immune responses.

Rational drug design, synthetic and artificial intelligence approaches for bioactive heterocycles: advances and perspectives.

Design and synthesis of 1,3,4-oxadiazole-tethered N-substituted isatin hybrids as SARS-CoV-2 main protease inhibitors: biological evaluation, kinetic investigation, and in silico studies.

Teaching diffusion models physics: reinforcement learning for physically valid diffusion-based docking.

Similarity-Enhanced Representation Learning of Non-Canonical Amino Acids for Therapeutic Peptide Modeling.

Machine Learning Approaches for Interpretable Antibody Property Prediction Using Structural Data.

New thinking for the next generation of antimalarials.

Related Experiment Videos

Molecular mimicry: CLIP, MHC Class II supermotifs and MAIDS

Related Concept Videos

Related Articles